MA09-hRPE cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MA09-hRPE cells, covering 2024-10-31 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy [Phase 1, Phase 2]